Disconnect Between Recurrence-Free Survival and Overall Survival for Newly Diagnosed Glioblastoma Patients Receiving Adjuvant Bevacizumab

被引：0
|
作者：
Arvold, N. D. [1 ]
Wen, P. Y. [1 ]
Reardon, D. A. [1 ]
Lee, E. Q. [1 ]
Pinnell, N. E. [1 ]
Christianson, L. W. [1 ]
Weiss, S. E. [2 ]
Dunn, I. F. [1 ]
Ligon, K. L. [1 ]
Alexander, B. M. [1 ]
机构：
[1] Dana Farber Brigham & Womens Canc Ctr, Boston, MA USA
[2] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2013年 / 87卷 / 02期
关键词：
D O I：
10.1016/j.ijrobp.2013.06.049
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S17 / S17
页数：1
相关论文
共 50 条
  • [1] Bevacizumab prolongs progression-free survival but not overall survival in newly diagnosed glioblastoma
    Hemi Malkki
    Nature Reviews Neurology, 2014, 10 (4) : 179 - 179
  • [2] Adjuvant Radiation Improves Recurrence-Free Survival and Overall Survival in Adrenocortical Carcinoma
    Gharzai, Laila A.
    Green, Michael D.
    Griffith, Kent A.
    Else, Tobias
    Mayo, Charles S.
    Hesseltine, Elizabeth
    Spratt, Daniel E.
    Ben-Josef, Edgar
    Sabolch, Aaron
    Miller, Barbara S.
    Worden, Francis
    Giordano, Thomas J.
    Hammer, Gary D.
    Jolly, Shruti
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2019, 104 (09): : 3743 - 3750
  • [3] Bevacizumab in combination with radiotherapy plus concomitant and adjuvant temozolomide for newly diagnosed glioblastoma: Update progression-free survival, overall survival, and toxicity
    Gruber, M. L.
    Raza, S.
    Gruber, D.
    Narayana, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [4] What is the difference between overall survival, recurrence-free survival and time-to-recurrence?
    Liu, Yang
    Yang, Tian
    Wei, Yun-Wei
    BRITISH JOURNAL OF SURGERY, 2020, 107 (12) : E634 - E634
  • [5] Recurrence-free survival in meningioma patients receiving radiation
    McGovern, S. L.
    Aldape, K. D.
    Munsell, M. F.
    Woo, S. Y.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (01): : S239 - S240
  • [6] Dexamethasone and overall survival and progression free survival in patients with newly diagnosed glioblastoma: a meta-analysis
    Arora, Harshit
    Mammi, Marco
    Patel, Naisargi Manishkumar
    Zyfi, Dea
    Dasari, Hema Reddy
    Yunusa, Ismael
    Simjian, Thomas
    Smith, Timothy R.
    Mekary, Rania A.
    JOURNAL OF NEURO-ONCOLOGY, 2024, 166 (01) : 17 - 26
  • [7] Dexamethasone and overall survival and progression free survival in patients with newly diagnosed glioblastoma: a meta-analysis
    Harshit Arora
    Marco Mammi
    Naisargi Manishkumar Patel
    Dea Zyfi
    Hema Reddy Dasari
    Ismael Yunusa
    Thomas Simjian
    Timothy R. Smith
    Rania A. Mekary
    Journal of Neuro-Oncology, 2024, 166 : 17 - 26
  • [8] The effect of smoking, obesity and diabetes on recurrence-free and overall survival in patients with stage III colon cancer receiving adjuvant chemotherapy
    Croese, Alex
    Gartrell, Richard
    Hiscock, Richard
    Lee, Margaret
    Gibbs, Peter
    Faragher, Ian
    Yeung, Justin
    CANCER REPORTS, 2021, 4 (03)
  • [9] Six-month progression-free survival as an alternative primary efficacy endpoint to overall survival in newly diagnosed glioblastoma patients receiving temozolomide
    Polley, Mei-Yin C.
    Lamborn, Kathleen R.
    Chang, Susan M.
    Butowski, Nicholas
    Clarke, Jennifer L.
    Prados, Michael
    NEURO-ONCOLOGY, 2010, 12 (03) : 274 - 282
  • [10] Letter to the editor: Dexamethasone and overall survival and progression free survival in patients with newly diagnosed glioblastoma: a meta-analysis
    Peter G. Zaki
    Sanjeev Herr
    Matthew J. Shepard
    Journal of Neuro-Oncology, 2024, 167 : 363 - 364
12345